imiquimod has been researched along with Actinic Reticuloid Syndrome in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 27 (93.10) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N | 1 |
| Bruckner-Tuderman, L; Burger, B; Has, C; Itin, P; Kohlhase, J; Volz, A | 1 |
| Benninghoff, B; Christophers, E; Meyer, T; Papadopoulos, L; Salasche, S; Stockfleth, E; Ulrich, C | 1 |
| Koenig, C; Walker, JK | 1 |
| del Rosso, JQ | 1 |
| Bianchi, L; Campione, E; Chimenti, S; Costanzo, A; Marulli, GC | 1 |
| Alam, M; Goldberg, LH; Silapunt, S | 1 |
| Moreno, G; Shumack, S; Tran, H | 1 |
| Dinehart, S; Fox, TL; Jorizzo, J; Lebwohl, M; Lee, JH; Lee, PK; Tawfik, N; Whiting, D | 1 |
| Campanelli, A; Salomon, D; Saurat, JH | 1 |
| Alomar, A; Bichel, J; Fox, TL; Gerritsen, MJ; Gupta, G; Lee, JH; Ortonne, JP; Serresi, S; Szeimies, RM | 1 |
| Benninghoff, B; Christophers, E; Sterry, W; Stockfleth, E | 1 |
| Anderson, NJ; Chakrabarty, AK; Geisse, JK; Mraz, S | 1 |
| Barnetson, RS; Halliday, GM; Lee, JH; McKane, S; Ooi, T; Slade, HB; Zhuang, L | 1 |
| Davey, V; Gupta, AK; Mcphail, H | 1 |
| Berman, B; Bienstock, L; Kuritzky, L; Mayeaux, EJ; Tyring, SK | 1 |
| Busch, JO; Meyer, T; Nindl, I; Schmook, T; Sterry, W; Stockfleth, E; Ulrich, C | 1 |
| Dixon, A | 1 |
| Alomar, A; Bichel, J; McRae, S | 1 |
| Dinehart, S; Fielder, S; Fox, TL; Jorizzo, J; Lee, JH; Ling, M; Matheson, R; McRae, S; Moore, JK | 1 |
| Falagas, ME; Papadavid, E; Stratigos, AJ | 1 |
| Perry, CM; Wagstaff, AJ | 1 |
| Anders, M; Birmachu, W; Bulbulian, BJ; Jin, J; Lee, J; Miller, RL; Raghavan, S; Slade, HB; Storey, L; Torres, A | 1 |
| Germain, M; Hamza, S; Skelton, H; Smith, K | 1 |
| Hengge, UR; Stark, R | 1 |
| Bonnekoh, B; Cerburkovas, O; Gollnick, H; Krause, M; Ulrich, J | 1 |
7 review(s) available for imiquimod and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
An update on newer topical therapies for actinic keratoses: advances and applications.
Topics: Administration, Topical; Aminoquinolines; Clinical Trials as Topic; Diclofenac; Humans; Imiquimod; Keratosis; Photosensitivity Disorders | 2003 |
Topical and light-based treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A | 2003 |
Imiquimod as a dermatological therapy.
Topics: Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Child; Child, Preschool; Condylomata Acuminata; Dermatologic Agents; Female; Humans; Imiquimod; Male; Molluscum Contagiosum; Photosensitivity Disorders; Randomized Controlled Trials as Topic | 2004 |
Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
Topics: Adjuvants, Immunologic; Aminoquinolines; Clinical Trials, Phase III as Topic; Confidence Intervals; Facial Dermatoses; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Keratosis; Ointments; Photosensitivity Disorders; Scalp Dermatoses; Time Factors | 2005 |
Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Consensus Development Conferences as Topic; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Risk Factors; Skin Neoplasms; Ultraviolet Rays | 2006 |
Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Carcinoma, Basal Cell; Humans; Imiquimod; Photosensitivity Disorders; Precancerous Conditions; Skin Diseases; Skin Neoplasms | 2007 |
Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Photosensitivity Disorders; Skin Diseases; Skin Neoplasms | 2007 |
11 trial(s) available for imiquimod and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Ointments; Photosensitivity Disorders; Reference Values; Severity of Illness Index; Treatment Outcome | 2002 |
Imiquimod as a dermatological therapy.
Topics: Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Child; Child, Preschool; Condylomata Acuminata; Dermatologic Agents; Female; Humans; Imiquimod; Male; Molluscum Contagiosum; Photosensitivity Disorders; Randomized Controlled Trials as Topic | 2004 |
Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Double-Blind Method; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Ointments; Pharmaceutical Vehicles; Photosensitivity Disorders; Ultraviolet Rays | 2004 |
Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology.
Topics: Aged; Aminoquinolines; Confidence Intervals; Double-Blind Method; Female; Humans; Imiquimod; Keratosis; Male; Photosensitivity Disorders | 2004 |
Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study.
Topics: Adjuvants, Immunologic; Aminoquinolines; Double-Blind Method; Follow-Up Studies; Humans; Imiquimod; Incidence; Keratosis; Ointments; Photosensitivity Disorders; Secondary Prevention | 2004 |
Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial.
Topics: Aged; Aminoquinolines; Biomarkers; Cell Movement; Dendritic Cells; Double-Blind Method; Drug Eruptions; Erythema; Female; Humans; Imiquimod; Immunophenotyping; Interferon Inducers; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Skin; T-Lymphocyte Subsets; Treatment Outcome | 2006 |
Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Drug Administration Schedule; Humans; Imiquimod; Immunocompromised Host; Immunologic Factors; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Pilot Projects; Precancerous Conditions; Skin Neoplasms; Transplants; Treatment Outcome | 2006 |
Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms; Sunlight; Treatment Outcome | 2007 |
Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.
Topics: Adult; Aminoquinolines; Double-Blind Method; Drug Administration Schedule; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis; Male; Ointments; Photosensitivity Disorders; Recurrence; Scalp Dermatoses; Treatment Outcome | 2007 |
Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Gene Expression; Humans; Imiquimod; Keratosis; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Photosensitivity Disorders; Scalp Dermatoses; Toll-Like Receptor 7; Treatment Outcome | 2007 |
Does imiquimod histologically rejuvenate ultraviolet radiation-damaged skin?
Topics: Aminoquinolines; Biopsy; Dermatologic Agents; Female; Humans; Imiquimod; Immunohistochemistry; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Pilot Projects; Rejuvenation; Signal Transduction; Skin; Skin Aging; Skin Diseases; Sunlight; Ultraviolet Rays | 2007 |
12 other study(ies) available for imiquimod and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Attitude of Health Personnel; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatology; Dermoscopy; Diclofenac; Disease Management; Guideline Adherence; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Photochemotherapy; Photosensitivity Disorders; Physicians; Practice Guidelines as Topic; Practice Patterns, Physicians'; Skin Neoplasms; Sunlight; Surveys and Questionnaires | 2014 |
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Basement Membrane; Blister; Carcinoma, Basal Cell; Cryosurgery; Delayed Diagnosis; Epidermolysis Bullosa; Female; Fluorouracil; Homozygote; Humans; Imiquimod; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Periodontal Diseases; Photosensitivity Disorders; Skin Neoplasms | 2010 |
Is imiquimod effective and safe for actinic keratosis?
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Evidence-Based Medicine; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Safety; Skin Neoplasms | 2003 |
Actinic keratosis treated with an immune response modifier: a case report of six patients.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Treatment Outcome | 2003 |
Imiquimod (Aldara) for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Drug Administration Schedule; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Skin Neoplasms | 2004 |
[Treatment of actinic keratosis with topical imiquimod (Aldara): the cutaneous erosion appears beneficial].
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Humans; Imiquimod; Keratosis; Photosensitivity Disorders | 2004 |
Systemic reactions to imiquimod (Aldara).
Topics: Administration, Topical; Aminoquinolines; Fatigue; Humans; Imiquimod; Photosensitivity Disorders | 2004 |
Aphthous ulcers associated with imiquimod and the treatment of actinic cheilitis.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Cheilitis; Cytokines; Female; Humans; Imiquimod; Male; Middle Aged; Photosensitivity Disorders; Stomatitis, Aphthous | 2005 |
Treating actinic keratoses with imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Facial Dermatoses; Humans; Imiquimod; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms | 2007 |
Topical imiquimod to treat intraepidermal carcinoma.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Nose; Photosensitivity Disorders; Precancerous Conditions; Skin Neoplasms; Thorax | 2001 |
[Disseminated actinic keratoses. Comparison of topical photodynamic therapy with 5-aminolevulinic acid and topical 5% imiquimod cream].
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Female; Follow-Up Studies; Humans; Imiquimod; Keratitis; Ointments; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Time Factors | 2001 |
New treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cryosurgery; Diclofenac; Gels; Imiquimod; Ointments; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents | 2002 |